Cargando…
Fortasyn Connect Improves Neuropsychiatric Symptoms in Patients with Mild Cognitive Impairment and Dementia: Results from a Retrospective Real-World Study
BACKGROUND: Behavioral and psychological symptoms of dementia (BPSD) manifest in the early stages of the disease and impair patients’ and caregivers’ quality of life. OBJECTIVE: To assess the effectiveness of the nutritional supplement Fortasyn Connect on BPSD for 12 months in people with mild cogni...
Autores principales: | Aguilar-Barberà, Miquel, Soler-Girabau, Paquita, Tabuenca-Martín, Ana Isabel, Prieto-del Val, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200227/ https://www.ncbi.nlm.nih.gov/pubmed/37066911 http://dx.doi.org/10.3233/JAD-221122 |
Ejemplares similares
-
The LipiDiDiet trial: what does it add to the current evidence for Fortasyn Connect in early Alzheimer’s disease?
por: Rasmussen, Jill
Publicado: (2019) -
High-Throughput Analysis of Astrocyte Cultures Shows Prevention of Reactive Astrogliosis by the Multi-Nutrient Combination Fortasyn Connect
por: Badia-Soteras, Aina, et al.
Publicado: (2022) -
Neuropsychiatric symptoms in Brazilians with mild cognitive impairment and dementia
por: Wilson, Robert S., et al.
Publicado: (2021) -
Neuropsychiatric Symptoms in Parkinson's Disease with Mild Cognitive Impairment and Dementia
por: Leroi, Iracema, et al.
Publicado: (2012) -
Using joint models to disentangle intervention effect types and baseline confounding: an application within an intervention study in prodromal Alzheimer’s disease with Fortasyn Connect
por: van Oudenhoven, Floor M., et al.
Publicado: (2019)